Ceramide function in the brain: When a slight tilt is enough

Cellular and Molecular Life Sciences

Volumn 70, Issue 2, 2013, Pages 181-203

  Mencarelli, Chiara ^a   Martinez Martinez, Pilar ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Ceramide; Neurodegeneration; Rafts; Sphingolipids

Indexed keywords

CERAMIDE; CERAMIDE 1 PHOSPHATE; CERAMIDE GLUCOSYLTRANSFERASE; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE; SERINE PALMITOYLTRANSFERASE; SPHINGANINE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE;

ALZHEIMER DISEASE; APOPTOSIS; CELLULAR DISTRIBUTION; ENDOPLASMIC RETICULUM; GAUCHER DISEASE; GLOBOID CELL LEUKODYSTROPHY; GOLGI COMPLEX; HUMAN; INTRACELLULAR SIGNALING; LIPID ANALYSIS; LIPID BILAYER; LIPID COMPOSITION; LIPID RAFT; LIPID TRANSPORT; LIPOGENESIS; LIPOLYSIS; MEMBRANE STRUCTURE; MYELINATION; NEUROMODULATION; NEUROPATHOLOGY; NIEMANN PICK DISEASE; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; REVIEW; STRUCTURE ANALYSIS; SYNAPTIC TRANSMISSION;

AGING; ANIMALS; BRAIN; CELL MEMBRANE; CERAMIDES; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; SYNAPTIC TRANSMISSION;

EID: 84872284081     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1038-x     Document Type: Review

References (312)

1. Pruett ST, Bushnev A, Hagedorn K, Adiga M, Haynes CA, Sullards MC, Liotta DC, Merrill AH Jr (2008) Biodiversity of sphingoid bases (sphingosines) and related amino alcohols. J Lipid Res 49(8):1621-1639. doi: 10.1194/jlr.R800012- JLR200
2. Kolesnick R (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110(1):3-8. doi: 10.1172/JCI16127
3. Bielawska A, Crane HM, Liotta D, Obeid LM, Hannun YA (1993) Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J Biol Chem 268(35):26226-26232
4. Karasavvas N, Erukulla RK, Bittman R, Lockshin R, Zakeri Z (1996) Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. The ceramide amide group is not required for apoptosis. Eur J Biochem 236(2):729-737
5. Michel C, van Echten-Deckert G (1997) Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum. FEBS Lett 416(2):153-155. doi: 10.1016/S0014-5793(97)01187-3
6. Michel C, van Echten-Deckert G, Rother J, Sandhoff K, Wang E, Merrill AH Jr (1997) Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem 272(36):22432-22437
7. Chalfant CE, Szulc Z, Roddy P, Bielawska A, Hannun YA (2004) The structural requirements for ceramide activation of serine-threonine protein phosphatases. J Lipid Res 45(3):496-506. doi: 10.1194/jlr.M300347-JLR200
8. Brockman HL, Momsen MM, Brown RE, He L, Chun J, Byun HS, Bittman R (2004) The 4,5-double bond of ceramide regulates its dipole potential, elastic properties, and packing behavior. Biophys J 87(3):1722-1731. doi: 10.1529/biophysj.104.044529
9. Li L, Tang X, Taylor KG, DuPre DB, Yappert MC (2002) Conformational characterization of ceramides by nuclear magnetic resonance spectroscopy. Biophys J 82(4):2067-2080. doi: 10.1016/S0006-3495(02)75554-9
10. Yappert MC, Borchman D (2004) Sphingolipids in human lens membranes: an update on their composition and possible biological implications. Chem Phys Lipids 129(1):1-20. doi: 10.1016/j.chemphyslip2003.12.003
11. van Blitterswijk WJ, van der Luit AH, Veldman RJ, Verheij M, Borst J (2003) Ceramide: second messenger or modulator of membrane structure and dynamics? Biochem J 369(Pt 2):199-211. doi: 10.1042/BJ20021528
12. Venkataraman K, Futerman AH (2000) Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol 10(10):408-412 pii: S0962-8924(00)01830-4
13. Kolesnick RN, Goni FM, Alonso A (2000) Compartmentalization of ceramide signaling: physical foundations and biological effects. J Cell Physiol 184(3):285-300. doi: 10.1002/1097-4652(200009)184:3<285:AID-JCP2>3.0.CO;2- 3
14. Mathias S, Dressler KA, Kolesnick RN (1991) Characterization of a ceramide-Activated protein kinase: stimulation by tumor necrosis factor alpha. Proc Natl Acad Sci USA 88(22):10009-10013
15. Huwiler A, Brunner J, Hummel R, Vervoordeldonk M, Stabel S, van den Bosch H, Pfeilschifter J (1996) Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-Activated protein kinase. Proc Natl Acad Sci USA 93(14):6959-6963
16. Hannun YA, Obeid LM (2002) The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem 277(29):25847-25850. doi: 10.1074/jbc.R200008200
17. Van Overloop H, Denizot Y, Baes M, Van Veldhoven PP (2007) On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase. Biol Chem 388(3):315-324. doi: 10.1515/BC.2007.035
18. Sot J, Bagatolli LA, Goni FM, Alonso A (2006) Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys J 90(3):903-914. doi: 10.1529/biophysj.105.067710
19. Ghidoni R, Sala G, Giuliani A (1999) Use of sphingolipid analogs: benefits and risks. Biochim Biophys Acta 1439(1):17-39 S1388-1981(99)00074-8
20. Di Paola M, Cocco T, Lorusso M (2000) Ceramide interaction with the respiratory chain of heart mitochondria. Biochemistry 39(22):6660-6668 pii: bi9924415
21. Helfrich W (1973) Elastic properties of lipid bilayers: theory and possible experiments. Z Naturforsch C 28(11):693-703
22. Bigay J, Casella JF, Drin G, Mesmin B, Antonny B (2005) ArfGAP1 responds to membrane curvature through the folding of a lipid packing sensor motif. EMBO J 24(13):2244-2253. doi: 10.1038/sj.emboj.7600714
23. Jao CC, Der-Sarkissian A, Chen J, Langen R (2004) Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling. Proc Natl Acad Sci USA 101(22):8331-8336. doi: 10.1073/pnas.0400553101
24. Veiga MP, Arrondo JL, Goni FM, Alonso A (1999) Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys J 76(1 Pt 1):342-350. doi: 10.1016/S0006-3495(99)77201-2
25. Holopainen JM, Subramanian M, Kinnunen PK (1998) Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry 37(50):17562-17570. doi: 10.1021/bi980915e
26. Holopainen JM, Lehtonen JY, Kinnunen PK (1997) Lipid microdomains in dimyristoylphosphatidylcholine-ceramide liposomes. Chem Phys Lipids 88(1):1-13 pii: S0009-3084(97)00040-6
27. Bai J, Pagano RE (1997) Measurement of spontaneous transfer and transbilayer movement of BODIPY-labeled lipids in lipid vesicles. Biochemistry 36(29):8840-8848. doi: 10.1021/bi970145r
28. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426(6968):803-809. doi: 10.1038/nature02188
29. Sot J, Goni FM, Alonso A (2005) Molecular associations and surface-Active properties of short- and long-N-Acyl chain ceramides. Biochim Biophys Acta 1711(1):12-19. doi: 10.1016/j.bbamem.2005.02.014
30. Zachowski A (1993) Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. Biochem J 294(Pt 1):1-14
31. Thudichum JLW (1884) The chemical constitution of the brain. Baillère, Tindall, and Cox, London
32. Karlsson KA (1970) Sphingolipid long chain bases. Lipids 5(11):878-891
33. Sullards MC, Allegood JC, Kelly S, Wang E, Haynes CA, Park H, Chen Y, Merrill AH Jr (2007) Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: inside-out sphingolipidomics. Methods Enzymol 432:83-115. doi: 10.1016/S0076-6879(07)32004- 1
34. Muse ED, Jurevics H, Toews AD, Matsushima GK, Morell P (2001) Parameters related to lipid metabolism as markers of myelination in mouse brain. J Neurochem 76(1):77-86
35. Togayachi A, Akashima T, Ookubo R, Kudo T, Nishihara S, Iwasaki H, Natsume A, Mio H, Inokuchi J, Irimura T, Sasaki K, Narimatsu H (2001) Molecular cloning and characterization of UDP-GlcNAc:lactosylceramide beta 1,3-N-Acetylglucosaminyltransferase (beta 3Gn-T5), an essential enzyme for the expression of HNK-1 and Lewis X epitopes on glycolipids. J Biol Chem 276(25):22032-22040. doi: 10.1074/jbc.M011369200
36. Henion TR, Zhou D, Wolfer DP, Jungalwala FB, Hennet T (2001) Cloning of a mouse beta 1,3 N-Acetylglucosaminyltransferase GlcNAc(beta 1,3)Gal(beta 1,4)Glc-ceramide synthase gene encoding the key regulator of lacto-series glycolipid biosynthesis. J Biol Chem 276(32):30261-30269. doi: 10.1074/jbc.M102979200
37. Hakomori S, Igarashi Y (1993) Gangliosides and glycosphingolipids as modulators of cell growth, adhesion, and transmembrane signaling. Adv Lipid Res 25:147-162
38. Satoh M, Fukushi Y, Kawamura S, Ohyama C, Saito S, Orikasa S, Nudleman E, Hakamori S (1992) Glycolipid expression in prostatic tissue and analysis of the antigen recognized by antiprostatic monoclonal antibody APG1. Urol Int 48(1):20-24
39. Sandhoff K, Kolter T (2003) Biosynthesis and degradation of mammalian glycosphingolipids. Philos Trans R Soc Lond B Biol Sci 358(1433):847-861. doi: 10.1098/rstb.2003.1265
40. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274(5294):1855-1859
41. Mandon EC, Ehses I, Rother J, van Echten G, Sandhoff K (1992) Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-Acyltransferase in mouse liver. J Biol Chem 267(16):11144-11148
42. Bionda C, Portoukalian J, Schmitt D, Rodriguez-Lafrasse C, Ardail D (2004) Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-Associated membrane) and/or mitochondria? Biochem J 382(Pt 2):527-533. doi: 10.1042/BJ20031819
43. Shimeno H, Soeda S, Sakamoto M, Kouchi T, Kowakame T, Kihara T (1998) Partial purification and characterization of sphingosine N-Acyltransferase (ceramide synthase) from bovine liver mitochondrion-rich fraction. Lipids 33(6):601-605
44. Dawkins JL, Hulme DJ, Brahmbhatt SB, Auer-Grumbach M, Nicholson GA (2001) Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I. Nat Genet 27(3):309-312. doi: 10.1038/85879
45. Stoffel W, Bister K (1974) Studies on the desaturation of sphinganine. Ceramide and sphingomyelin metabolism in the rat and in BHK 21 cells in tissue culture. Hoppe Seylers Z Physiol Chem 355(8):911-923
46. Pewzner-Jung Y, Ben-Dor S, Futerman AH (2006) When do Lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J Biol Chem 281(35):25001-25005. doi: 10.1074/jbc.R600010200
47. Riebeling C, Allegood JC, Wang E, Merrill AH Jr, Futerman AH (2003) Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 278(44):43452-43459. doi: 10.1074/jbc.M307104200
48. Lahiri S, Futerman AH (2005) LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem 280(40):33735-33738. doi: 10.1074/jbc.M506485200
49. Marasas WF, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, Missmer SA, Cabrera J, Torres O, Gelderblom WC, Allegood J, Martinez C, Maddox J, Miller JD, Starr L, Sullards MC, Roman AV, Voss KA, Wang E, Merrill AH Jr (2004) Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 134(4):711-716
50. Pomorski T, Hrafnsdottir S, Devaux PF, van Meer G (2001) Lipid distribution and transport across cellular membranes. Semin Cell Dev Biol 12(2):139-148. doi: 10.1006/scdb.2000.0231
51. Sandhoff K, van Echten G (1993) Ganglioside metabolism-topology and regulation. Adv Lipid Res 26:119-142
52. Jeckel D, Karrenbauer A, Burger KN, van Meer G, Wieland F (1992) Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol 117(2):259-267
53. D'Angelo G, Polishchuk E, Di Tullio G, Santoro M, Di Campli A, Godi A, West G, Bielawski J, Chuang CC, van der Spoel AC, Platt FM, Hannun YA, Polishchuk R, Mattjus P, De Matteis MA (2007) Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide. Nature 449(7158):62-67. doi: 10.1038/nature06097
54. Halter D, Neumann S, van Dijk SM, Wolthoorn J, de Maziere AM, Vieira OV, Mattjus P, Klumperman J, van Meer G, Sprong H (2007) Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J Cell Biol 179(1):101-115. doi: 10.1083/jcb.200704091
55. Lannert H, Bunning C, Jeckel D, Wieland FT (1994) Lactosylceramide is synthesized in the lumen of the Golgi apparatus. FEBS Lett 342(1):91-96
56. Fukasawa M, Nishijima M, Hanada K (1999) Genetic evidence for ATP-dependent endoplasmic reticulum-to-Golgi apparatus trafficking of ceramide for sphingomyelin synthesis in Chinese hamster ovary cells. J Cell Biol 144(4):673-685
57. Funakoshi T, Yasuda S, Fukasawa M, Nishijima M, Hanada K (2000) Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J Biol Chem 275(39):29938-29945. doi: 10.1074/jbc.M004470200
58. van Meer G, Holthuis JC (2000) Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta 1486(1):145-170 pii: S1388-1981(00)00054-8
59. Kumagai K, Yasuda S, Okemoto K, Nishijima M, Kobayashi S, Hanada K (2005) CERT mediates intermembrane transfer of various molecular species of ceramides. J Biol Chem 280(8):6488-6495. doi: 10.1074/jbc.M409290200
60. Rao RP, Yuan C, Allegood JC, Rawat SS, Edwards MB, Wang X, Merrill AH Jr, Acharya U, Acharya JK (2007) Ceramide transfer protein function is essential for normal oxidative stress response and lifespan. Proc Natl Acad Sci USA 104(27):11364-11369. doi: 10.1073/pnas.0705049104
61. Wang X, Rao RP, Kosakowska-Cholody T, Masood MA, Southon E, Zhang H, Berthet C, Nagashim K, Veenstra TK, Tessarollo L, Acharya U, Acharya JK (2009) Mitochondrial degeneration and not apoptosis is the primary cause of embryonic lethality in ceramide transfer protein mutant mice. J Cell Biol 184(1):143-158. doi: 10.1083/jcb.200807176
62. Mencarelli C, Losen M, Hammels C, De Vry J, Hesselink MK, Steinbusch HW, De Baets MH, Martinez-Martinez P (2009) The ceramide transporter and the Goodpasture antigen binding protein: one protein-one function? J Neurochem 113 (6):1369-1386. doi: 10.1111/j.1471-4159.2010.06673.x
63. Granero-Molto F, Sarmah S, O'Rear L, Spagnoli A, Abrahamson D, Saus J, Hudson BG, Knapik EW (2008) Goodpasture antigen-binding protein and its spliced variant, ceramide transfer protein, have different functions in the modulation of apoptosis during zebrafish development. J Biol Chem 283(29):20495-20504. doi: 10.1074/jbc.M801806200
64. Mencarelli C, Hammels C, Van Den Broeck J, Losen M, Steinbusch H, Revert F, Saus J, Hopkins DA, De Baets MH, Steinbusch HW, Martinez-Martinez P (2009) The expression of the Goodpasture antigen-binding protein (ceramide transporter) in adult rat brain. J Chem Neuroanat 38(2):97-105. doi: 10.1016/j.jchemneu. 2009.06.005
65. Raya A, Revert-Ros F, Martinez-Martinez P, Navarro S, Rosello E, Vieites B, Granero F, Forteza J, Saus J (2000) Goodpasture antigen-binding protein, the kinase that phosphorylates the goodpasture antigen, is an alternatively spliced variant implicated in autoimmune pathogenesis. J Biol Chem 275(51):40392-40399. doi: 10.1074/jbc.M002769200
66. Zandman-Goddard G, Blank M (2002) Apoptosis and autoimmunity. Isr Med Assoc J 4(9):722-724
67. Ullman MD, Radin NS (1974) The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver. J Biol Chem 249(5):1506-1512
68. Huitema K, van den Dikkenberg J, Brouwers JF, Holthuis JC (2004) Identification of a family of animal sphingomyelin synthases. EMBO J 23(1):33-44. doi: 10.1038/sj.emboj.7600034
69. Jeckel D, Karrenbauer A, Birk R, Schmidt RR, Wieland F (1990) Sphingomyelin is synthesized in the cis Golgi. FEBS Lett 261(1):155-157
70. Futerman AH, Stieger B, Hubbard AL, Pagano RE (1990) Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J Biol Chem 265(15):8650-8657
71. Tafesse FG, Ternes P, Holthuis JC (2006) The multigenic sphingomyelin synthase family. J Biol Chem 281(40):29421-29425. doi: 10.1074/jbc.R600021200
72. Linke T, Wilkening G, Sadeghlar F, Mozcall H, Bernardo K, Schuchman E, Sandhoff K (2001) Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins. J Biol Chem 276(8):5760-5768. doi: 10.1074/jbc.M006846200
73. van Echten G, Birk R, Brenner-Weiss G, Schmidt RR, Sandhoff K (1990) Modulation of sphingolipid biosynthesis in primary cultured neurons by long chain bases. J Biol Chem 265(16):9333-9339
74. Perry DK, Hannun YA (1998) The role of ceramide in cell signaling. Biochim Biophys Acta 1436(1-2):233-243 S0005-2760(98)00145-3
75. Reynolds CP, Maurer BJ, Kolesnick RN (2004) Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206(2):169-180. doi: 10.1016/j.canlet.2003.08.034
76. Okazaki T, Bielawska A, Domae N, Bell RM, Hannun YA (1994) Characteristics and partial purification of a novel cytosolic, magnesium-independent, neutral sphingomyelinase activated in the early signal transduction of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem 269(6):4070-4077
77. Schissel SL, Jiang X, Tweedie-Hardman J, Jeong T, Camejo EH, Najib J, Rapp JH, Williams KJ, Tabas I (1998) Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem 273(5):2738-2746
78. Barnholz Y, Roitman A, Gatt S (1966) Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J Biol Chem 241(16):3731-3737
79. Otterbach B, Stoffel W (1995) Acid sphingomyelinase-deficient mice mimic the neurovisceral form of human lysosomal storage disease (Niemann-Pick disease). Cell 81(7):1053-1061 pii: S0092-8674(05)80010-8
80. 2+-stimulated sphingomyelinase in fetal bovine serum. J Biol Chem 264(10):5358-5363
81. Schissel SL, Schuchman EH, Williams KJ, Tabas I (1996) Zn-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 271(31):18431-18436
82. Schissel SL, Keesler GA, Schuchman EH, Williams KJ, Tabas I (1998) The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273(29):18250-18259
83. Tomiuk S, Zumbansen M, Stoffel W (2000) Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J Biol Chem 275(8):5710-5717
84. Neuberger Y, Shogomori H, Levy Z, Fainzilber M, Futerman AH (2000) A lyso-platelet activating factor phospholipase C, originally suggested to be a neutral-sphingomyelinase, is located in the endoplasmic reticulum. FEBS Lett 469(1):44-46 pii: S0014-5793(00)01235-7
85. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W (1998) Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA 95(7):3638-3643
86. Gatt S, Gottesdiner T (1976) Solubilization of sphingomyelinase by isotonic extraction of rat brain lysosomes. J Neurochem 26(2):421-422
87. Rao BG, Spence MW (1976) Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res 17(5):506-515
88. Marchesini N, Luberto C, Hannun YA (2003) Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J Biol Chem 278(16):13775-13783. doi: 10.1074/jbc.M212262200
89. Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, Kronke M (2006) Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-Anchored protein. J Biol Chem 281(19):13784-13793. doi: 10.1074/jbc.M511306200
90. Cheng Y, Tauschel HD, Nilsson A, Duan RD (1999) Ursodeoxycholic acid increases the activities of alkaline sphingomyelinase and caspase-3 in the rat colon. Scand J Gastroenterol 34(9):915-920
91. Ybe JA, Wakeham DE, Brodsky FM, Hwang PK (2000) Molecular structures of proteins involved in vesicle fusion. Traffic 1(6):474-479
92. Wakeham DE, Ybe JA, Brodsky FM, Hwang PK (2000) Molecular structures of proteins involved in vesicle coat formation. Traffic 1(5):393-398
93. Smith ER, Merrill AH Jr (1995) Differential roles of de novo sphingolipid biosynthesis and turnover in the burst of free sphingosine and sphinganine, and their 1-phosphates and N-Acyl-derivatives, that occurs upon changing the medium of cells in culture. J Biol Chem 270(32):18749-18758
94. Gillard BK, Clement RG, Marcus DM (1998) Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways. Glycobiology 8(9):885-890
95. Riboni L, Bassi R, Caminiti A, Prinetti A, Viani P, Tettamanti G (1998) Metabolic fate of exogenous sphingosine in neuroblastoma neuro2A cells. Dose-dependence and biological effects. Ann N Y Acad Sci 845:46-56
96. Chatelut M, Leruth M, Harzer K, Dagan A, Marchesini S, Gatt S, Salvayre R, Courtoy P, Levade T (1998) Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue. FEBS Lett 426(1):102-106 pii: S0014-5793(98)00325-1
97. Tani M, Okino N, Mitsutake S, Tanigawa T, Izu H, Ito M (2000) Purification and characterization of a neutral ceramidase from mouse liver. A single protein catalyzes the reversible reaction in which ceramide is both hydrolyzed and synthesized. J Biol Chem 275(5):3462-3468
98. Gatt S (1963) Enzymic Hydrolysis and Synthesis of Ceramides. J Biol Chem 238:3131-3133
99. Sugita M, Willians M, Dulaney JT, Moser HW (1975) Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase. Biochim Biophys Acta 398(1):125-131
100. Bar J, Linke T, Ferlinz K, Neumann U, Schuchman EH, Sandhoff K (2001) Molecular analysis of acid ceramidase deficiency in patients with Farber disease. Hum Mutat 17(3):199-209. doi: 10.1002/humu.5
101. El Bawab S, Roddy P, Qian T, Bielawska A, Lemasters JJ, Hannun YA (2000) Molecular cloning and characterization of a human mitochondrial ceramidase. J Biol Chem 275(28):21508-21513. doi: 10.1074/jbc.M002522200
102. Shiraishi T, Imai S, Uda Y (2003) The presence of ceramidase activity in liver nuclear membrane. Biol Pharm Bull 26(6):775-779
103. El Bawab S, Bielawska A, Hannun YA (1999) Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain. J Biol Chem 274(39):27948-27955
104. Mao C, Xu R, Szulc ZM, Bielawska A, Galadari SH, Obeid LM (2001) Cloning and characterization of a novel human alkaline ceramidase. A mammalian enzyme that hydrolyzes phytoceramide. J Biol Chem 276(28):26577-26588. doi: 10.1074/jbc.M102818200
105. Birbes H, El Bawab S, Obeid LM, Hannun YA (2002) Mitochondria and ceramide: intertwined roles in regulation of apoptosis. Adv Enzyme Regul 42:113-129 pii: S0065257101000267
106. Gatt S, Rapport MM (1966) Enzymic hydrolysis of sphingolipids: Hydrolysis of ceramide lactoside by an enzyme from rat brain. Biochem J 101(3):680-686
107. El Bawab S, Birbes H, Roddy P, Szulc ZM, Bielawska A, Hannun YA (2001) Biochemical characterization of the reverse activity of rat brain ceramidase. A CoA-independent and fumonisin B1-insensitive ceramide synthase. J Biol Chem 276(20):16758-16766. doi: 10.1074/jbc.M009331200
108. Siskind LJ (2005) Mitochondrial ceramide and the induction of apoptosis. J Bioenerg Biomembr 37(3):143-153. doi: 10.1007/s10863-005-6567-7
109. Ghosh TK, Bian J, Gill DL (1994) Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem 269(36):22628-22635
110. Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, Spiegel S (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147(3):545-558
111. Stoffel W, Assmann G (1970) Metabolism of sphingosine bases. XV. Enzymatic degradation of 4t-sphingenine 1-phosphate (sphingosine 1-phosphate) to 2t-hexadecen-1-Al and ethanolamine phosphate. Hoppe Seylers Z Physiol Chem 351(8):1041-1049
112. Ballou LR, Chao CP, Holness MA, Barker SC, Raghow R (1992) Interleukin-1-mediated PGE2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267(28):20044-20050
113. Hla T (2003) Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 47(5):401-407 pii: S104366180300046X
114. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381(6585):800-803. doi: 10.1038/381800a0
115. Spiegel S, Olivera A, Carlson RO (1993) The role of sphingosine in cell growth regulation and transmembrane signaling. Adv Lipid Res 25:105-129
116. Sugiura M, Kono K, Liu H, Shimizugawa T, Minekura H, Spiegel S, Kohama T (2002) Ceramide kinase, a novel lipid kinase. Molecular cloning and functional characterization. J Biol Chem 277(26):23294-23300. doi: 10.1074/jbc.M201535200
117. Bajjalieh SM, Martin TF, Floor E (1989) Synaptic vesicle ceramide kinase. A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. J Biol Chem 264(24):14354-14360
118. Kolesnick RN, Hemer MR (1990) Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity. J Biol Chem 265(31):18803-18808
119. Wijesinghe DS, Lamour NF, Gomez-Munoz A, Chalfant CE (2007) Ceramide kinase and ceramide-1-phosphate. Methods Enzymol 434:265-292. doi: 10.1016/S0076-6879(07)34015-9
120. Gomez-Munoz A, Kong JY, Salh B, Steinbrecher UP (2004) Ceramide-1-phosphate blocks apoptosis through inhibition of acid sphingomyelinase in macrophages. J Lipid Res 45(1):99-105. doi: 10.1194/jlr.M300158-JLR200
121. Arana L, Gangoiti P, Ouro A, Trueba M, Gomez-Munoz A Ceramide and ceramide 1-phosphate in health and disease. Lipids Health Dis 9:15. doi: 10.1186/1476-511X-9-15
122. Gangoiti P, Granado MH, Arana L, Ouro A, Gomez-Munoz A Activation of protein kinase C-Alpha is essential for stimulation of cell proliferation by ceramide 1-phosphate. FEBS Lett 584 (3):517-524. doi: 10.1016/j.febslet.2009.11. 086
123. Bajjalieh S, Batchelor R (2000) Ceramide kinase. Methods Enzymol 311:207-215
124. Mitsutake S, Kim TJ, Inagaki Y, Kato M, Yamashita T, Igarashi Y (2004) Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J Biol Chem 279(17):17570-17577. doi: 10.1074/jbc.M312885200
125. Shinghal R, Scheller RH, Bajjalieh SM (1993) Ceramide 1-phosphate phosphatase activity in brain. J Neurochem 61(6):2279-2285
126. Lamour NF, Stahelin RV, Wijesinghe DS, Maceyka M, Wang E, Allegood JC, Merrill AH Jr, Cho W, Chalfant CE (2007) Ceramide kinase uses ceramide provided by ceramide transport protein: localization to organelles of eicosanoid synthesis. J Lipid Res 48(6):1293-1304. doi: 10.1194/jlr.M700083-JLR200
127. Boath A, Graf C, Lidome E, Ullrich T, Nussbaumer P, Bornancin F (2008) Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase: comparative analysis to glucosylceramide and sphingomyelin. J Biol Chem 283(13):8517-8526. doi: 10.1074/jbc.M707107200
128. Spiegel S, Milstien S (2000) Sphingosine-1-phosphate: signaling inside and out. FEBS Lett 476(1-2):55-57 pii: S0014-5793(00)01670-7
129. Sengupta P, Baird B, Holowka D (2007) Lipid rafts, fluid/fluid phase separation, and their relevance to plasma membrane structure and function. Semin Cell Dev Biol 18(5):583-590. doi: 10.1016/j.semcdb.2007.07.010
130. Brown DA, London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136. doi: 10.1146/annurev.cellbio.14.1. 111
131. van Meer G (1989) Lipid traffic in animal cells. Annu Rev Cell Biol 5:247-275. doi: 10.1146/annurev.cb.05.110189.001335
132. Op den Kamp JA (1979) Lipid asymmetry in membranes. Annu Rev Biochem 48:47-71. doi: 10.1146/annurev.bi.48.070179.000403
133. Buccoliero R, Futerman AH (2003) The roles of ceramide and complex sphingolipids in neuronal cell function. Pharmacol Res 47(5):409-419 pii: S1043661803000495
134. Ogawa-Goto K, Abe T (1998) Gangliosides and glycosphingolipids of peripheral nervous system myelins-A minireview. Neurochem Res 23(3):305-310
135. Smondyrev AM, Berkowitz ML (1999) Structure of dipalmitoylphosphatidylcholine/cholesterol bilayer at low and high cholesterol concentrations: molecular dynamics simulation. Biophys J 77(4):2075-2089. doi: 10.1016/S0006-3495(99)77049-9
136. Cremesti AE, Goni FM, Kolesnick R (2002) Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 531(1):47-53 pii: S0014579302034890
137. Simons K, Vaz WL (2004) Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33:269-295. doi: 10.1146/annurev.biophys.32. 110601.141803
138. Simons K, Ikonen E (1997) Functional rafts in cell membranes. Nature 387(6633):569-572. doi: 10.1038/42408
139. London E (2002) Insights into lipid raft structure and formation from experiments in model membranes. Curr Opin Struct Biol 12(4):480-486 pii: S0959440X02003512
140. Schroeder R, London E, Brown D (1994) Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-Anchored proteins: GPI-Anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci USA 91(25):12130-12134
141. Pralle A, Keller P, Florin EL, Simons K, Horber JK (2000) Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 148(5):997-1008
142. Kusumi A, Suzuki K (2005) Toward understanding the dynamics of membrane-raft-based molecular interactions. Biochim Biophys Acta 1746(3):234-251. doi: 10.1016/j.bbamcr.2005.10.001
143. Henderson RM, Edwardson JM, Geisse NA, Saslowsky DE (2004) Lipid rafts: feeling is believing. News Physiol Sci 19:39-43
144. Brown DA, Rose JK (1992) Sorting of GPI-Anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68(3):533-544 pii: 0092-8674(92)90189-J
145. Lichtenberg D, Goni FM, Heerklotz H (2005) Detergent-resistant membranes should not be identified with membrane rafts. Trends Biochem Sci 30(8):430-436. doi: 10.1016/j.tibs.2005.06.004
146. Douglass AD, Vale RD (2005) Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells. Cell 121(6):937-950. doi: 10.1016/j.cell.2005. 04.009
147. Harder T, Scheiffele P, Verkade P, Simons K (1998) Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 141(4):929-942
148. Ritchie K, Iino R, Fujiwara T, Murase K, Kusumi A (2003) The fence and picket structure of the plasma membrane of live cells as revealed by single molecule techniques (Review). Mol Membr Biol 20(1):13-18 pii: 2V247XX9PK6UGLGK
149. Gagescu R, Gruenberg J, Smythe E (2000) Membrane dynamics in endocytosis: structure-function relationship. Traffic 1(1):84-88 pii: tra010112
150. Dermine JF, Duclos S, Garin J, St-Louis F, Rea S, Parton RG, Desjardins M (2001) Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J Biol Chem 276(21):18507-18512. doi: 10.1074/jbc.M101113200
151. Fivaz M, Vilbois F, Thurnheer S, Pasquali C, Abrami L, Bickel PE, Parton RG, van der Goot FG (2002) Differential sorting and fate of endocytosed GPI-Anchored proteins. EMBO J 21(15):3989-4000. doi: 10.1093/emboj/cdf398
152. Fullekrug J, Simons K (2004) Lipid rafts and apical membrane traffic. Ann N Y Acad Sci 1014:164-169
153. Steer CJ, Bisher M, Blumenthal R, Steven AC (1984) Detection of membrane cholesterol by filipin in isolated rat liver coated vesicles is dependent upon removal of the clathrin coat. J Cell Biol 99(1 Pt 1):315-319
154. Coxey RA, Pentchev PG, Campbell G, Blanchette-Mackie EJ (1993) Differential accumulation of cholesterol in Golgi compartments of normal and Niemann-Pick type C fibroblasts incubated with LDL: a cytochemical freeze-fracture study. J Lipid Res 34(7):1165-1176
155. Sobo K, Le Blanc I, Luyet PP, Fivaz M, Ferguson C, Parton RG, Gruenberg J, van der Goot FG (2007) Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS ONE 2(9):e851. doi: 10.1371/journal.pone.0000851
156. Eberle HB, Serrano RL, Fullekrug J, Schlosser A, Lehmann WD, Lottspeich F, Kaloyanova D, Wieland FT, Helms JB (2002) Identification and characterization of a novel human plant pathogenesis-related protein that localizes to lipid-enriched microdomains in the Golgi complex. J Cell Sci 115(Pt 4):827-838
157. Brown DA (2006) Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21:430-439. doi: 10.1152/physiol.00032. 2006
158. Abrami L, Fivaz M, Kobayashi T, Kinoshita T, Parton RG, van der Goot FG (2001) Cross-talk between caveolae and glycosylphosphatidylinositol-rich domains. J Biol Chem 276(33):30729-30736. doi: 10.1074/jbc.M102039200
159. Pierini LM, Maxfield FR (2001) Flotillas of lipid rafts fore and aft. Proc Natl Acad Sci USA 98(17):9471-9473. doi: 10.1073/pnas.181353098
160. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1(1):31-39. doi: 10.1038/35036052
161. Manes S, Mira E, Gomez-Mouton C, Lacalle RA, Keller P, Labrador JP, Martinez AC (1999) Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J 18(22):6211-6220. doi: 10.1093/emboj/18.22.6211
162. Holthuis JC, van Meer G, Huitema K (2003) Lipid microdomains, lipid translocation and the organization of intracellular membrane transport (Review). Mol Membr Biol 20(3):231-241 pii: PTRP84BE92YEE71X
163. Salaun C, James DJ, Chamberlain LH (2004) Lipid rafts and the regulation of exocytosis. Traffic 5(4):255-264. doi: 10.1111/j.1600-0854.2004.0162.x
164. Salaun C, Gould GW, Chamberlain LH (2005) Lipid raft association of SNARE proteins regulates exocytosis in PC12 cells. J Biol Chem 280(20):19449-19453. doi: 10.1074/jbc.M501923200
165. Mendez AJ, Lin G, Wade DP, Lawn RM, Oram JF (2001) Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 276(5):3158-3166. doi: 10.1074/jbc.M007717200
166. Anderson RG, Jacobson K (2002) A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296(5574):1821-1825. doi: 10.1126/science.1068886
167. Lingwood D, Simons K Lipid rafts as a membrane-organizing principle. Science 327 (5961):46-50. doi: 10.1126/science.1174621
168. Kasahara K, Sanai Y (2000) Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconj J 17(3-4):153-162
169. Melkonian KA, Ostermeyer AG, Chen JZ, Roth MG, Brown DA (1999) Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem 274(6):3910-3917
170. Kurzchalia TV, Parton RG (1999) Membrane microdomains and caveolae. Curr Opin Cell Biol 11(4):424-431 pii: cbb401
171. Babiychuk EB, Monastyrskaya K, Burkhard FC, Wray S, Draeger A (2002) Modulating signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to lipid rafts. FASEB J 16(10):1177-1184. doi: 10.1096/fj.02-0070com
172. Bollinger CR, Teichgraber V, Gulbins E (2005) Ceramide-enriched membrane domains. Biochim Biophys Acta 1746(3):284-294. doi: 10.1016/j.bbamcr.2005.09.001
173. Megha London E (2004) Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem 279(11):9997-10004. doi: 10.1074/jbc.M309992200
174. Nurminen TA, Holopainen JM, Zhao H, Kinnunen PK (2002) Observation of topical catalysis by sphingomyelinase coupled to microspheres. J Am Chem Soc 124(41):12129-12134 pii: ja017807r
175. Megha Sawatzki P, Kolter T, Bittman R, London E (2007) Effect of ceramide N-Acyl chain and polar headgroup structure on the properties of ordered lipid domains (lipid rafts). Biochim Biophys Acta 1768(9):2205-2212. doi: 10.1016/j.bbamem.2007.05.007
176. Berridge MJ (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem 56:159-193. doi: 10.1146/annurev.bi.56.070187.001111
177. Besterman JM, Duronio V, Cuatrecasas P (1986) Rapid formation of diacylglycerol from phosphatidylcholine: a pathway for generation of a second messenger. Proc Natl Acad Sci USA 83(18):6785-6789
178. Lopez-Montero I, Monroy F, Velez M, Devaux PF Ceramide: from lateral segregation to mechanical stress. Biochim Biophys Acta 1798 (7):1348-1356. doi: 10.1016/j.bbamem.2009.12.007
179. Gomez-Fernandez JC, Corbalan-Garcia S (2007) Diacylglycerols, multivalent membrane modulators. Chem Phys Lipids 148(1):1-25. doi: 10.1016/j.chemphyslip. 2007.04.003
180. Siegel DP, Banschbach J, Alford D, Ellens H, Lis LJ, Quinn PJ, Yeagle PL, Bentz J (1989) Physiological levels of diacylglycerols in phospholipid membranes induce membrane fusion and stabilize inverted phases. Biochemistry 28(9):3703-3709
181. Harder T, Engelhardt KR (2004) Membrane domains in lymphocytes - from lipid rafts to protein scaffolds. Traffic 5(4):265-275. doi: 10.1111/j.1600-0854.2003.00163.x
182. Grassme H, Cremesti A, Kolesnick R, Gulbins E (2003) Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22(35):5457-5470. doi: 10.1038/sj.onc.1206540
183. Ledesma MD, Brugger B, Bunning C, Wieland FT, Dotti CG (1999) Maturation of the axonal plasma membrane requires upregulation of sphingomyelin synthesis and formation of protein-lipid complexes. EMBO J 18(7):1761-1771. doi: 10.1093/emboj/18.7.1761
184. Maekawa S, Iino S, Miyata S (2003) Molecular characterization of the detergent-insoluble cholesterol-rich membrane microdomain (raft) of the central nervous system. Biochim Biophys Acta 1610 (2):261-270. pii: S0005273603000233
185. Malchiodi-Albedi F, Contrusciere V, Raggi C, Fecchi K, Rainaldi G, Paradisi S, Matteucci A, Santini MT, Sargiacomo M, Frank C, Gaudiano MC (1802) Diociaiuti M lipid raft disruption protects mature neurons against amyloid oligomer toxicity. Biochim Biophys Acta 4:406-415. doi: 10.1016/j.bbadis.2010. 01.007
186. Gil C, Soler-Jover A, Blasi J, Aguilera J (2005) Synaptic proteins and SNARE complexes are localized in lipid rafts from rat brain synaptosomes. Biochem Biophys Res Commun 329(1):117-124. doi: 10.1016/j.bbrc.2005.01.111
187. Lv JH, He L, Sui SF (2008) Lipid rafts association of synaptotagmin I on synaptic vesicles. Biochemistry (Mosc) 73 (3):283-288. pii:BCM73030349
188. Hering H, Lin CC, Sheng M (2003) Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23 (8):3262-3271. pii: 23/8/3262
189. Bruses JL, Chauvet N, Rutishauser U (2001) Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J Neurosci 21 (2):504-512. pii: 21/2/504
190. Becher A, White JH, McIlhinney RA (2001) The gamma-Aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J Neurochem 79(4):787-795
191. Suzuki T, Ito J, Takagi H, Saitoh F, Nawa H, Shimizu H (2001) Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Brain Res Mol Brain Res 89 (1-2):20-28. pii:S0169328X01000511
192. Besshoh S, Bawa D, Teves L, Wallace MC, Gurd JW (2005) Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem 93(1):186-194. doi: 10.1111/j.1471-4159.2004.03009.x
193. Povlsen GK, Ditlevsen DK (2008) The neural cell adhesion molecule NCAM and lipid rafts. Neurochem Res. doi: 10.1007/s11064-008-9759-9
194. Delling M, Wischmeyer E, Dityatev A, Sytnyk V, Veh RW, Karschin A, Schachner M (2002) The neural cell adhesion molecule regulates cell-surface delivery of G-protein-Activated inwardly rectifying potassium channels via lipid rafts. J Neurosci 22(16):7154-7164 pii: 2002670222/16/7154
195. Pristera A, Okuse K Building excitable membranes: lipid rafts and multiple controls on trafficking of electrogenic molecules. Neuroscientist. doi: 10.1177/1073858410393977
196. Kamiguchi H (2006) The region-specific activities of lipid rafts during axon growth and guidance. J Neurochem 98(2):330-335. doi: 10.1111/j.1471-4159. 2006.03888.x
197. Vinson M, Rausch O, Maycox PR, Prinjha RK, Chapman D, Morrow R, Harper AJ, Dingwall C, Walsh FS, Burbidge SA, Riddell DR (2003) Lipid rafts mediate the interaction between myelin-Associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol Cell Neurosci 22 (3):344-352. pii: S1044743102000313
198. Copani A, Uberti D, Sortino MA, Bruno V, Nicoletti F, Memo M (2001) Activation of cell-cycle-Associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci 24 (1):25-31. pii: S0166223600016635
199. Kolesnick R, Hannun YA (1999) Ceramide and apoptosis. Trends Biochem Sci 24 (6):224-225; author reply 227. pii: S0968-0004(99)01408-5
200. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259(5102):1769-1771
201. Novgorodov SA, Szulc ZM, Luberto C, Jones JA, Bielawski J, Bielawska A, Hannun YA, Obeid LM (2005) Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J Biol Chem 280(16):16096-16105. doi: 10.1074/jbc.M411707200
202. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82 (3):405-414. pii: 0092-8674(95)90429-8
203. Dbaibo GS, El-Assaad W, Krikorian A, Liu B, Diab K, Idriss NZ, El-Sabban M, Driscoll TA, Perry DK, Hannun YA (2001) Ceramide generation by two distinct pathways in tumor necrosis factor alpha-induced cell death. FEBS Lett 503 (1):7-12. pii: S0014-5793(01)02625-4
204. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R (1996) Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86(2):189-199. doi: S0092-8674(00)80091-4
205. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH Jr (1991) Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J Biol Chem 266(22):14486-14490
206. Merrill AH Jr, van Echten G, Wang E, Sandhoff K (1993) Fumonisin B1 inhibits sphingosine (sphinganine) N-Acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem 268(36):27299-27306
207. Furuya S, Mitoma J, Makino A, Hirabayashi Y (1998) Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. J Neurochem 71(1):366-377
208. Tepper AD, Ruurs P, Wiedmer T, Sims PJ, Borst J, van Blitterswijk WJ (2000) Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J Cell Biol 150(1):155-164
209. Son JH, Yoo HH, Kim DH (2007) Activation of de novo synthetic pathway of ceramides is responsible for the initiation of hydrogen peroxide-induced apoptosis in HL-60 cells. J Toxicol Environ Health A 70(15-16):1310-1318. doi: 10.1080/15287390701434364
210. Blazquez C, Galve-Roperh I, Guzman M (2000) De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. FASEB J 14(14):2315-2322. doi: 10.1096/fj.00-0122com
211. Perry DK, Carton J, Shah AK, Meredith F, Uhlinger DJ, Hannun YA (2000) Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J Biol Chem 275(12):9078-9084
212. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M (1994) Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78(6):1005-1015 pii: 0092-8674(94)90275-5
213. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R (1995) Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J 14(23):5859-5868
214. Adam D, Wiegmann K, Adam-Klages S, Ruff A, Kronke M (1996) A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J Biol Chem 271(24):14617-14622
215. Adam-Klages S, Schwandner R, Adam D, Kreder D, Bernardo K, Kronke M (1998) Distinct adapter proteins mediate acid versus neutral sphingomyelinase activation through the p55 receptor for tumor necrosis factor. J Leukoc Biol 63(6):678-682
216. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74(5):845-853 pii: 0092-8674(93)90464-2
217. Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84(2):299-308 pii: S0092-8674(00)80984-8
218. Wiegmann K, Schwandner R, Krut O, Yeh WC, Mak TW, Kronke M (1999) Requirement of FADD for tumor necrosis factor-induced activation of acid sphingomyelinase. J Biol Chem 274(9):5267-5270
219. Grassme H, Schwarz H, Gulbins E (2001) Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophys Res Commun 284(4):1016-1030. doi: 10.1006/bbrc.2001.5045
220. Zeidan YH, Hannun YA (2007) Activation of acid sphingomyelinase by protein kinase Cdelta-mediated phosphorylation. J Biol Chem 282(15):11549-11561. doi: 10.1074/jbc.M609424200
221. Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, Schwandner R, Weber T, Saftig P, Peters C, Brunner J, Kronke M, Schutze S (1999) Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18(19):5252-5263. doi: 10.1093/emboj/18.19.5252
222. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, Peter ME (1999) Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274(32):22532-22538
223. Heinrich M, Neumeyer J, Jakob M, Hallas C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzold A, Hethke A, Schutze S (2004) Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 11(5):550-563. doi: 10.1038/sj.cdd.4401382
224. Adam D, Adam-Klages S, Kronke M (1995) Identification of p55 tumor necrosis factor receptor-Associated proteins that couple to signaling pathways not initiated by the death domain. J Inflamm 47(1-2):61-66
225. Galadari S, Kishikawa K, Kamibayashi C, Mumby MC, Hannun YA (1998) Purification and characterization of ceramide-Activated protein phosphatases. Biochemistry 37(32):11232-11238. doi: 10.1021/bi980911+
226. Dobrowsky RT, Hannun YA (1993) Ceramide-Activated protein phosphatase: partial purification and relationship to protein phosphatase 2A. Adv Lipid Res 25:91-104
227. Dbaibo GS, Pushkareva MY, Jayadev S, Schwarz JK, Horowitz JM, Obeid LM, Hannun YA (1995) Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 92(5):1347-1351
228. Ruvolo PP, Deng X, Ito T, Carr BK, May WS (1999) Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 274(29):20296-20300
229. Wolff RA, Dobrowsky RT, Bielawska A, Obeid LM, Hannun YA (1994) Role of ceramide-Activated protein phosphatase in ceramide-mediated signal transduction. J Biol Chem 269(30):19605-19609
230. Reyes JG, Robayna IG, Delgado PS, Gonzalez IH, Aguiar JQ, Rosas FE, Fanjul LF, Galarreta CM (1996) c-Jun is a downstream target for ceramide-Activated protein phosphatase in A431 cells. J Biol Chem 271(35):21375-21380
231. Zeidan YH, Wu BX, Jenkins RW, Obeid LM, Hannun YA (2008) A novel role for protein kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J 22(1):183-193. doi: 10.1096/fj.07-8967com
232. Hernandez OM, Discher DJ, Bishopric NH, Webster KA (2000) Rapid activation of neutral sphingomyelinase by hypoxia-reoxygenation of cardiac myocytes. Circ Res 86(2):198-204
233. Jin J, Hou Q, Mullen TD, Zeidan YH, Bielawski J, Kraveka JM, Bielawska A, Obeid LM, Hannun YA, Hsu YT (2008) Ceramide generated by sphingomyelin hydrolysis and the salvage pathway is involved in hypoxia/reoxygenation-induced Bax redistribution to mitochondria in NT-2 cells. J Biol Chem 283(39):26509-26517. doi: 10.1074/jbc.M801597200
234. Bruno AP, Laurent G, Averbeck D, Demur C, Bonnet J, Bettaieb A, Levade T, Jaffrezou JP (1998) Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ 5(2):172-182. doi: 10.1038/sj.cdd.4400330
235. Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, Hazen-Martin DJ, Obeid LM, Hannun YA, Smith GK (2002) Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem 277(43):41128-41139. doi: 10.1074/jbc.M206747200
236. Liu YY, Yu JY, Yin D, Patwardhan GA, Gupta V, Hirabayashi Y, Holleran WM, Giuliano AE, Jazwinski SM, Gouaze-Andersson V, Consoli DP, Cabot MC (2008) A role for ceramide in driving cancer cell resistance to doxorubicin. FASEB J 22(7):2541-2551. doi: 10.1096/fj.07-092981
237. Cremesti A, Paris F, Grassme H, Holler N, Tschopp J, Fuks Z, Gulbins E, Kolesnick R (2001) Ceramide enables fas to cap and kill. J Biol Chem 276(26):23954-23961. doi: 10.1074/jbc.M101866200
238. Thevissen K, Francois IE, Winderickx J, Pannecouque C, Cammue BP (2006) Ceramide involvement in apoptosis and apoptotic diseases. Mini Rev Med Chem 6(6):699-709
239. Kirschnek S, Paris F, Weller M, Grassme H, Ferlinz K, Riehle A, Fuks Z, Kolesnick R, Gulbins E (2000) CD95-mediated apoptosis in vivo involves acid sphingomyelinase. J Biol Chem 275(35):27316-27323. doi: 10.1074/jbc.M002957200
240. Garcia-Ruiz C, Colell A, Mari M, Morales A, Calvo M, Enrich C, Fernandez-Checa JC (2003) Defective TNF-Alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111(2):197-208. doi: 10.1172/JCI16010
241. Segui B, Andrieu-Abadie N, Adam-Klages S, Meilhac O, Kreder D, Garcia V, Bruno AP, Jaffrezou JP, Salvayre R, Kronke M, Levade T (1999) CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J Biol Chem 274(52):37251-37258
242. Liu JJ, Wang JY, Hertervig E, Cheng Y, Nilsson A, Duan RD (2000) Activation of neutral sphingomyelinase participates in ethanol-induced apoptosis in Hep G2 cells. Alcohol Alcohol 35(6):569-573
243. Levy M, Castillo SS, Goldkorn T (2006) nSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Biochem Biophys Res Commun 344(3):900-905. doi: 10.1016/j.bbrc.2006.04.013
244. Jaffrezou JP, Levade T, Bettaieb A, Andrieu N, Bezombes C, Maestre N, Vermeersch S, Rousse A, Laurent G (1996) Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 15(10):2417-2424
245. Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, Gulbins E (2003) Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9(3):322-330. doi: 10.1038/nm823
246. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, Grassme H, Gulbins E (2001) Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 6(6):431-439
247. Grassme H, Riehle A, Wilker B, Gulbins E (2005) Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 280(28):26256-26262. doi: 10.1074/jbc.M500835200
248. Gomez del Pulgar T, Velasco G, Sanchez C, Haro A, Guzman M (2002) De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 363(Pt 1):183-188
249. Kalen A, Borchardt RA, Bell RM (1992) Elevated ceramide levels in GH4C1 cells treated with retinoic acid. Biochim Biophys Acta 1125(1):90-96 pii: 0005-2760(92)90160-W
250. Kroesen BJ, Pettus B, Luberto C, Busman M, Sietsma H, de Leij L, Hannun YA (2001) Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J Biol Chem 276(17):13606-13614. doi: 10.1074/jbc.M009517200
251. Gulbins E (2003) Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol Res 47(5):393-399 pii: S1043661803000525
252. Heinrich M, Wickel M, Winoto-Morbach S, Schneider-Brachert W, Weber T, Brunner J, Saftig P, Peters C, Kronke M, Schutze S (2000) Ceramide as an activator lipid of cathepsin D. Adv Exp Med Biol 477:305-315. doi: 10.1007/0-306-46826-3-33
253. Mattson MP, Duan W, Maswood N (2002) How does the brain control lifespan? Ageing Res Rev 1(2):155-165 pii: S1568163701000034
254. Cutler RG, Mattson MP (2001) Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev 122(9):895-908 pii: S0047-6374(01)00246-9
255. Kolter T, Sandhoff K (2006) Sphingolipid metabolism diseases. Biochim Biophys Acta 1758(12):2057-2079. doi: 10.1016/j.bbamem.2006.05.027
256. Schorling S, Vallee B, Barz WP, Riezman H, Oesterhelt D (2001) Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae. Mol Biol Cell 12(11):3417-3427
257. D'Mello NP, Childress AM, Franklin DS, Kale SP, Pinswasdi C, Jazwinski SM (1994) Cloning and characterization of LAG1, a longevity-Assurance gene in yeast. J Biol Chem 269(22):15451-15459
258. Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, Jiang JC, Jazwinski SM, Hannun YA, Obeid LM, Ogretmen B (2004) Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem 279(43):44311-44319. doi: 10.1074/jbc.M406920200
259. Wooten-Blanks LG, Song P, Senkal CE, Ogretmen B (2007) Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1. FASEB J 21(12):3386-3397. doi: 10.1096/fj.07-8621com
260. Lee HW, Blasco MA, Gottlieb GJ, Horner JW 2nd, Greider CW, DePinho RA (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392(6676):569-574. doi: 10.1038/33345
261. Blasco MA, Funk W, Villeponteau B, Greider CW (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269(5228):1267-1270
262. Prowse KR, Greider CW (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92(11):4818-4822
263. Caporaso GL, Lim DA, Alvarez-Buylla A, Chao MV (2003) Telomerase activity in the subventricular zone of adult mice. Mol Cell Neurosci 23(4):693-702 pii: S1044743103001039
264. Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM (1995) Role of ceramide in cellular senescence. J Biol Chem 270(51):30701-30708
265. Venable ME, Yin X (2009) Ceramide induces endothelial cell senescence. Cell Biochem Funct 27(8):547-551. doi: 10.1002/cbf.1605
266. Venable ME, Webb-Froehlich LM, Sloan EF, Thomley JE (2006) Shift in sphingolipid metabolism leads to an accumulation of ceramide in senescence. Mech Ageing Dev 127(5):473-480. doi: 10.1016/j.mad.2006.01.003
267. Sacket SJ, Chung HY, Okajima F, Im DS (2009) Increase in sphingolipid catabolic enzyme activity during aging. Acta Pharmacol Sin 30(10):1454-1461. doi: 10.1038/aps.2009.136
268. Crocker AC, Farber S (1958) Niemann-Pick disease: a review of eighteen patients. Medicine (Baltimore) 37(1):1-95
269. Sugita M, Dulaney JT, Moser HW (1972) Ceramidase deficiency in Farber's disease (lipogranulomatosis). Science 178(65):1100-1102
270. Levade T, Moser HW, Fensom AH, Harzer K, Moser AB, Salvayre R (1995) Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells. J Neurol Sci 134(1-2):108-114
271. Ehlert K, Frosch M, Fehse N, Zander A, Roth J, Vormoor J (2007) Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr Rheumatol Online J 5:15. doi: 10.1186/1546-0096-5-15
272. Adams DO (1976) The granulomatous inflammatory response. A review. Am J Pathol 84(1):164-192
273. Suzuki K (1985) Genetic galactosylceramidase deficiency (globoid cell leukodystrophy, Krabbe disease) in different mammalian species. Neurochem Pathol 3(1):53-68
274. Kanazawa T, Nakamura S, Momoi M, Yamaji T, Takematsu H, Yano H, Sabe H, Yamamoto A, Kawasaki T, Kozutsumi Y (2000) Inhibition of cytokinesis by a lipid metabolite, psychosine. J Cell Biol 149(4):943-950
275. White AB, Givogri MI, Lopez-Rosas A, Cao H, van Breemen R, Thinakaran G, Bongarzone ER (2009) Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture. J Neurosci 29(19):6068-6077. doi: 10.1523/JNEUROSCI.5597-08.2009
276. Farooqui AA, Horrocks LA, Farooqui T (2007) Modulation of inflammation in brain: a matter of fat. J Neurochem 101(3):577-599. doi: 10.1111/j.1471-4159. 2006.04371.x
277. Suzuki K (1994) A genetic demyelinating disease globoid cell leukodystrophy: studies with animal models. J Neuropathol Exp Neurol 53(4):359-363
278. Brady RO, Kanfer JN, Bradley RM, Shapiro D (1966) Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest 45(7):1112-1115. doi: 10.1172/JCI105417
279. Orvisky E, Park JK, LaMarca ME, Ginns EI, Martin BM, Tayebi N, Sidransky E (2002) Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. Mol Genet Metab 76(4):262-270 pii: S1096719202001178
280. Brady RO, Kanfer JN, Mock MB, Fredrickson DS (1966) The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae. Proc Natl Acad Sci USA 55(2):366-369
281. Zhang JR, Coleman T, Langmade SJ, Scherrer DE, Lane L, Lanier MH, Feng C, Sands MS, Schaffer JE, Semenkovich CF, Ory DS (2008) Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking. J Clin Invest 118(6):2281-2290. doi: 10.1172/JCI32561
282. Lampert P, Hooks J, Gibbs CJ Jr, Gajdusek DC (1971) Altered plasma membranes in experimental scrapie. Acta Neuropathol 19(2):81-93
283. Svennerholm L, Bostrom K, Helander CG, Jungbjer B (1991) Membrane lipids in the aging human brain. J Neurochem 56(6):2051-2059
284. Smith HL, Howland MC, Szmodis AW, Li Q, Daemen LL, Parikh AN, Majewski J (2009) Early stages of oxidative stress-induced membrane permeabilization: a neutron reflectometry study. J Am Chem Soc 131(10):3631-3638. doi: 10.1021/ja807680m
285. Vetrivel KS (1801) Thinakaran G Membrane rafts in Alzheimer's disease beta-Amyloid production. Biochim Biophys Acta 8:860-867. doi: 10.1016/j.bbalip.2010.03.007
286. Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ (2003) Exclusively targeting beta-secretase to lipid rafts by GPI-Anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 100(20):11735-11740. doi: 10.1073/pnas.1635130100
287. Tun H, Marlow L, Pinnix I, Kinsey R, Sambamurti K (2002) Lipid rafts play an important role in A beta biogenesis by regulating the beta-secretase pathway. J Mol Neurosci 19(1-2):31-35. doi: 10.1007/s12031-002-0007-5
288. Marlow L, Cain M, Pappolla MA, Sambamurti K (2003) Beta-secretase processing of the Alzheimer's amyloid protein precursor (APP). J Mol Neurosci 20(3):233-239. doi: 10.1385/JMN:20:3:233
289. Vetrivel KS, Cheng H, Kim SH, Chen Y, Barnes NY, Parent AT, Sisodia SS, Thinakaran G (2005) Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J Biol Chem 280(27):25892-25900. doi: 10.1074/jbc.M503570200
290. Urano Y, Hayashi I, Isoo N, Reid PC, Shibasaki Y, Noguchi N, Tomita T, Iwatsubo T, Hamakubo T, Kodama T (2005) Association of active gamma-secretase complex with lipid rafts. J Lipid Res 46(5):904-912. doi: 10.1194/jlr.M400333- JLR200
291. Yanagisawa K, Odaka A, Suzuki N, Ihara Y (1995) GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat Med 1(10):1062-1066
292. Mao Y, Shang Z, Imai Y, Hoshino T, Tero R, Tanaka M, Yamamoto N, Yanagisawa K, Urisu T Surface-induced phase separation of a sphingomyelin/ cholesterol/ganglioside GM1-planar bilayer on mica surfaces and microdomain molecular conformation that accelerates Abeta oligomerization. Biochim Biophys Acta 1798 (6):1090-1099. doi: 10.1016/j.bbamem.2010.03.003
293. Choo-Smith LP, Surewicz WK (1997) The interaction between Alzheimer amyloid beta(1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett 402(2-3):95-98 pii: S0014-5793(96)01504-9
294. Hooper NM (2005) Glycosylation and GPI anchorage of the prion protein. Adv Exp Med Biol 564:95-96. doi: 10.1007/0-387-25515-X-14
295. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 272(10):6324-6331
296. Hooper NM (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 33(Pt 2):335-338. doi: 10.1042/BST0330335
297. Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH (2004) Lipid rafts mediate the synaptic localization of alpha-synuclein. J Neurosci 24(30):6715-6723. doi: 10.1523/JNEUROSCI.1594-04.2004
298. Fabelo N, Martin V, Santpere G, Marin R, Torrent L, Ferrer I, Diaz M Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol Med 17 (9-10):1107-1118. doi: 10.2119/molmed.2011.00119
299. Martin V, Fabelo N, Santpere G, Puig B, Marin R, Ferrer I, Diaz M Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. J Alzheimers Dis 19 (2):489-502. doi: 10.3233/JAD-2010-1242
300. Ariga T, Jarvis WD, Yu RK (1998) Role of sphingolipid-mediated cell death in neurodegenerative diseases. J Lipid Res 39(1):1-16
301. Nicotera P, Leist M, Manzo L (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol Sci 20(2):46-51 pii: S0165-6147(99)01304-8
302. Satoi H, Tomimoto H, Ohtani R, Kitano T, Kondo T, Watanabe M, Oka N, Akiguchi I, Furuya S, Hirabayashi Y, Okazaki T (2005) Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. Neuroscience 130(3):657-666. doi: 10.1016/j.neuroscience.2004.08.056
303. Han X, D MH, McKeel DW, Jr., Kelley J, Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82 (4):809-818. pii: 0997
304. Kalanj S, Kracun I, Rosner H, Cosovic C (1991) Regional distribution of brain gangliosides in Alzheimer's disease. Neurol Croat 40(4):269-281
305. Huang Y, Tanimukai H, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2004) Elevation of the level and activity of acid ceramidase in Alzheimer's disease brain. Eur J Neurosci 20(12):3489-3497. doi: 10.1111/j.1460-9568.2004.03852.x
306. He X, Huang Y, Li B, Gong CX, Schuchman EH Deregulation of sphingolipid metabolism in Alzheimer's disease. Neurobiol Aging 31 (3):398-408. doi: 10.1016/j.neurobiolaging.2008.05.010
307. Grimm MO, Grosgen S, Rothhaar TL, Burg VK, Hundsdorfer B, Haupenthal VJ, Friess P, Muller U, Fassbender K, Riemenschneider M, Grimm HS, Hartmann T Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease. Int J Alzheimers Dis 2011:695-413. doi: 10.4061/2011/695413
308. Brann AB, Scott R, Neuberger Y, Abulafia D, Boldin S, Fainzilber M, Futerman AH (1999) Ceramide signaling downstream of the p75 neurotrophin receptor mediates the effects of nerve growth factor on outgrowth of cultured hippocampal neurons. J Neurosci 19(19):8199-8206
309. Schwarz A, Futerman AH (1997) Distinct roles for ceramide and glucosylceramide at different stages of neuronal growth. J Neurosci 17(9):2929-2938
310. Jarvis WD, Fornari FA Jr, Browning JL, Gewirtz DA, Kolesnick RN, Grant S (1994) Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem 269(50):31685-31692
311. Kolesnick RN, Kronke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60:643-665. doi: 10.1146/annurev.physiol.60.1.643
312. Goodman Y, Mattson MP (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J Neurochem 66(2):869-872